Literature DB >> 8499567

Active site and exosite binding of alpha-thrombin.

A Tulinsky1, X Qiu.   

Abstract

alpha-thrombin possesses at least three independent binding sites for substrate, inhibitor and effector molecules. The S1 subsite of the active site is specific for an arginine side group while S2 is a more extended apolar site. The fibrinogen recognition exosite, which usually operates in concert with catalysis, appears to circumnavigate about a third of the surface, although evidence suggests that recognition of a tetra- or pentapeptide sequence is sufficient. Another highly electropositive region of thrombin, which binds the second kringle of prothrombin through salt bridges, is also most likely the heparin binding site. All three sites display distinct binding modes with different molecules. In the active site, these can arise from different optical enantiomorphs combined with reversal of main chain direction, while in the fibrinogen anion binding exosite, certain peptide side chains (hydrophobic) are tolerated of imprecision or are not relevant for binding or undergo a conformational change in substrate binding. Such apparently indiscriminant behaviour easily accounts for the diversity of thrombin functions at the molecular level.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499567     DOI: 10.1097/00001721-199304000-00012

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  9 in total

1.  Determinants of the factor IX mutational spectrum in haemophilia B: an analysis of missense mutations using a multi-domain molecular model of the activated protein.

Authors:  A I Wacey; M Krawczak; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

2.  Heparin enhances the catalytic activity of des-ETW-thrombin.

Authors:  C A Goodwin; J J Deadman; B F Le Bonniec; S Elgendy; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

3.  Synthesis, structure, and structure-activity relationships of divalent thrombin inhibitors containing an alpha-keto-amide transition-state mimetic.

Authors:  R Krishnan; A Tulinsky; G P Vlasuk; D Pearson; P Vallar; P Bergum; T K Brunck; W C Ripka
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

4.  Bradykinin antagonizes the effects of alpha-thrombin.

Authors:  W D Ehringer; M J Edwards; R D Gray; F N Miller
Journal:  Inflammation       Date:  1997-06       Impact factor: 4.092

5.  Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site.

Authors:  J H Matthews; R Krishnan; M J Costanzo; B E Maryanoff; A Tulinsky
Journal:  Biophys J       Date:  1996-11       Impact factor: 4.033

6.  Rational design of hirulog-type inhibitors of thrombin.

Authors:  U Egner; G A Hoyer; W D Schleuning
Journal:  J Comput Aided Mol Des       Date:  1994-10       Impact factor: 3.686

7.  Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.

Authors:  V Ganesh; A Y Lee; J Clardy; A Tulinsky
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

8.  Diversity and selective pressures of anticoagulants in three medicinal leeches (Hirudinida: Hirudinidae, Macrobdellidae).

Authors:  Sebastian Kvist; Gi-Sik Min; Mark E Siddall
Journal:  Ecol Evol       Date:  2013-03-05       Impact factor: 2.912

Review 9.  Protein crystallography and infectious diseases.

Authors:  C L Verlinde; E A Merritt; F Van den Akker; H Kim; I Feil; L F Delboni; S C Mande; S Sarfaty; P H Petra; W G Hol
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.